Diminished systemic levels of antimicrobial peptides in tuberculous lymphadenitis and their reversal after anti-tuberculosis treatment
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in Tuberculosis
- Vol. 122, 101934
- https://doi.org/10.1016/j.tube.2020.101934
Abstract
No abstract availableKeywords
Funding Information
- ICMR (3/1/3/PDF (14)/2016-HRD)
- Division of Intramural Research, NIAID, NIH.
This publication has 44 references indexed in Scilit:
- Targeting Mycobacterium tuberculosis and Other Microbial Pathogens Using Improved Synthetic Antibacterial PeptidesAntimicrobial Agents and Chemotherapy, 2013
- Defensin Production by Human Limbo-Corneal Fibroblasts Infected with MycobacteriaPathogens, 2013
- Defensins in innate immunityCell and tissue research, 2010
- Biology and clinical relevance of granulysinTissue Antigens, 2009
- Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2Proceedings of the National Academy of Sciences, 2007
- Impaired Expression of Perforin and Granulysin in CD8+T Cells at the Site of Infection in Human Chronic Pulmonary TuberculosisInfection and Immunity, 2007
- Decreased serum granulysin levels in childhood tuberculosis which reverse after therapyTuberculosis, 2007
- Role of Polymorphonuclear Leukocyte-Derived Serine Proteinases in Defense againstActinobacillus actinomycetemcomitansInfection and Immunity, 2006
- Role of Human Neutrophil Peptide–1 as a Possible Adjunct to Antituberculosis ChemotherapyThe Journal of Infectious Diseases, 2004
- Antimicrobial peptides of multicellular organismsNature, 2002